BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu Y, Smith D, Frazier E, Hoerle R, Ehrich M, Zhang C. The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine. Biomaterials 2016;106:228-39. [PMID: 27569868 DOI: 10.1016/j.biomaterials.2016.08.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Feng Q, Jiang X. Microfluidic Synthesis of Gd-Based Nanoparticles for Fast and Ultralong MRI Signals in the Solid Tumor. Adv Healthc Mater 2019;8:e1900672. [PMID: 31529786 DOI: 10.1002/adhm.201900672] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hu Y, Smith D, Zhao Z, Harmon T, Pentel PR, Ehrich M, Zhang C. Alum as an adjuvant for nanoparticle based vaccines: A case study with a hybrid nanoparticle-based nicotine vaccine. Nanomedicine 2019;20:102023. [PMID: 31181264 DOI: 10.1016/j.nano.2019.102023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Schijns V, Fernández-Tejada A, Barjaktarović Ž, Bouzalas I, Brimnes J, Chernysh S, Gizurarson S, Gursel I, Jakopin Ž, Lawrenz M, Nativi C, Paul S, Pedersen GK, Rosano C, Ruiz-de-Angulo A, Slütter B, Thakur A, Christensen D, Lavelle EC. Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunol Rev 2020;296:169-90. [PMID: 32594569 DOI: 10.1111/imr.12889] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
4 Fraleigh NL, Oliva R, Lewicky JD, Martel AL, Acevedo R, Dagmar GR, Le HT. Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes. PLoS One 2019;14:e0221708. [PMID: 31442285 DOI: 10.1371/journal.pone.0221708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Hu Y, Zhao Z, Harmon T, Pentel PR, Ehrich M, Zhang C. Paradox of PEGylation in fabricating hybrid nanoparticle-based nicotine vaccines. Biomaterials 2018;182:72-81. [PMID: 30107271 DOI: 10.1016/j.biomaterials.2018.08.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
6 Green JJ. Immunoengineering has arrived. J Biomed Mater Res A 2021;109:397-403. [PMID: 32588490 DOI: 10.1002/jbm.a.37041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Smith LC, George O. Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models. Neuropharmacology 2020;178:108225. [PMID: 32758566 DOI: 10.1016/j.neuropharm.2020.108225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Laudenbach M, Baruffaldi F, Robinson C, Carter P, Seelig D, Baehr C, Pravetoni M. Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose. Sci Rep 2018;8:5508. [PMID: 29615715 DOI: 10.1038/s41598-018-23777-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
9 Zeigler DF, Roque R, Clegg CH. Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides. PLoS One 2017;12:e0178835. [PMID: 28570609 DOI: 10.1371/journal.pone.0178835] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
10 Zhao Z, Hu Y, Harmon T, Pentel PR, Ehrich M, Zhang C. Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins. Nanomedicine 2018;14:1655-65. [PMID: 29719216 DOI: 10.1016/j.nano.2018.04.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ji H, Wu G, Li Y, Wang K, Xue X, You S, Wu S, Ren T, He B, Shi X. Self-Albumin Camouflage of Carrier Protein Prevents Nontarget Antibody Production for Enhanced LDL-C Immunotherapy. Adv Healthc Mater 2020;9:e1901203. [PMID: 31814301 DOI: 10.1002/adhm.201901203] [Reference Citation Analysis]
12 Zhao Z, Harris B, Hu Y, Harmon T, Pentel PR, Ehrich M, Zhang C. Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction. Biomaterials 2018;155:165-75. [PMID: 29179132 DOI: 10.1016/j.biomaterials.2017.11.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
13 Ceballos-Alcantarilla E, Abad-Somovilla A, Agulló C, Abad-Fuentes A, Mercader JV. Protein-Free Hapten-Carbon Nanotube Constructs Induce the Secondary Immune Response. Bioconjug Chem 2017;28:1630-8. [PMID: 28598600 DOI: 10.1021/acs.bioconjchem.6b00653] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hu Y, Zhao Z, Ehrich M, Zhang C. Formulation of Nanovaccines toward an Extended Immunity against Nicotine. ACS Appl Mater Interfaces 2021;13:27972-82. [PMID: 34105952 DOI: 10.1021/acsami.1c07049] [Reference Citation Analysis]
15 Fraleigh NL, Lewicky JD, Martel AL, Diaz-Mitoma F, Le HT. Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine. Vaccines (Basel) 2021;9:118. [PMID: 33546163 DOI: 10.3390/vaccines9020118] [Reference Citation Analysis]
16 Hu Y, Smith D, Frazier E, Zhao Z, Zhang C. Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine. Mol Pharm 2021;18:1293-304. [PMID: 33497574 DOI: 10.1021/acs.molpharmaceut.0c01153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ozgen MH, Blume S. The continuing search for an addiction vaccine. Vaccine 2019;37:5485-90. [PMID: 31266675 DOI: 10.1016/j.vaccine.2019.06.074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Zhao Y, Li Z, Zhu X, Cao Y, Chen X. Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface. Biomaterials 2020;249:120030. [PMID: 32315864 DOI: 10.1016/j.biomaterials.2020.120030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]